Search

everythinglearnresearchcommunity

for

Search:↓

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Some medications can cause acne, and stopping these drugs is the main treatment.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

The document concludes that scalp conditions have various causes and can present in many different ways.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.